Hepatitis C virus vaccine design: focus on the humoral immune response

Despite the recent development of safe and highly effective direct-acting antivirals, hepatitis C virus (HCV) infection remains a significant health problem. In 2016, the World Health Organization set out to reduce the rate of new HCV infections by 90% by 2030. Still, global control of the virus doe...

Descripción completa

Detalles Bibliográficos
Autores principales: Sepulveda-Crespo, Daniel, Resino, Salvador, Martinez, Isidoro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338099/
https://www.ncbi.nlm.nih.gov/pubmed/32631318
http://dx.doi.org/10.1186/s12929-020-00669-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338099/
https://www.ncbi.nlm.nih.gov/pubmed/32631318
http://dx.doi.org/10.1186/s12929-020-00669-4

Ejemplares similares